InvestorsHub Logo
Followers 152
Posts 15815
Boards Moderated 1
Alias Born 03/01/2005

Re: Biotech Pharmer post# 5415

Saturday, 03/14/2020 11:48:28 PM

Saturday, March 14, 2020 11:48:28 PM

Post# of 5907
If they meet the mile stones they will get paid up to 391 million from the partner plus high single digit to low double digit royalties from kirin who wanted the non ocology rights. I bet that if they do gamble and get a fast track approval working with that Japanese company for a coronavirus flu treatment this stock will rock with a 400 million payment plus royalties. That would this to $50 imo. Good luck to all.

https://www.businesswire.com/news/home/20190801005415/en/Kyowa-Kirin-Buys-Tivozanib-Non-Oncology-Rights-AVEO